By 2030, Ultraviolet Germicidal Irradiation market to reach $1.1 Billion

Saturday, January 6, 2024

Ultraviolet Germicidal Irradiation in 2022 experienced robust competition internationally, with the main competitors competing for market share. The competitive presence of the market was branded as sturdy, lively, niche, or trivial for different players. The pandemic situation played an important role in improving the adoption of UVGI technology for internal air quality, disinfection, and cleansing. UVC irradiation was mainly operative in deactivating the replication of the COVID-19 virus, contributing to its extensive usage. 

One of the segments examined in the report, Air Disinfectant, by the end of the analysis period is expected to record 11.5% CAGR and reach US$940.6 Million. For the next 8-year period, growth in the Surface Disinfectant segment is estimated at 9.7% CAGR. 

Furthermore, UVGI technology unlocked paths for the cleansing and reuse of N95 masks and personal protective equipment. As the market presented strong growth because of the augmented focus on prevention of infection, the obtainability of low-cost alternatives continued to be a restricting factor. In general, 2022 emphasized a year of disturbance and change in the UVGI market, motivated by the worldwide pandemic and a rising urgency for germicidal solutions.

The US Ultraviolet Germicidal Irradiation is estimated at US$149.1 Million in the year 2024.  

« Back to Page

• Canada airline workers shocked to experience no financial support for the sector